EHS
EHS

Letter by Aw et al Regarding Article, “Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention” [Letter to the Editor]

EHS
Back to top button